TL;DR

At Solvion Health in Houston, testosterone therapy (TRT) restores clinically low testosterone to normal ranges after proper testing. With guideline-based dosing and regular monitoring, many men see improvements in libido, energy, mood, body composition, bone density, and markers tied to healthy aging. Large modern trials show no increase in major cardiovascular events in appropriate patients; we closely track hematocrit, blood pressure, and fertility effects.

What Is Testosterone Therapy (TRT)?

TRT is prescription testosterone—via gel, injections, patches, pellets, or other routes—used to treat hypogonadism, where the body cannot produce enough testosterone. The goal is to restore physiologic (normal) levels, not bodybuilding doses. Clinical guidelines outline who qualifies, how to test, how to treat, and how to monitor safely.

TRT vs. “Boosters”

Over-the-counter “testosterone boosters” are not a substitute for medical therapy. They’re not approved for hypogonadism and lack robust evidence for consistent, meaningful improvements. Medical TRT is diagnosis-driven and lab-monitored.

Do You Actually Need It? (Symptoms + Diagnosis)

Common symptoms include low libido, fatigue, depressed mood, increased body fat, and reduced strength. Diagnosis requires morning blood tests (repeated to confirm low total testosterone); checking free testosterone helps when SHBG is abnormal. Good care screens for reversible causes (sleep apnea, obesity, medications, thyroid disease, diabetes) and addresses these first where appropriate.

Evidence-Based Benefits

• Sexual function & libido: Randomized trials show moderate, significant improvements in sexual activity, desire, and erectile function.
• Mood & vitality: Many men report better energy and mood; benefits vary and build over weeks to months.
• Body composition & performance: TRT tends to increase lean mass and reduce fat mass; training and nutrition remain essential.
• Bone health: Increases in bone mineral density and estimated strength—especially in the spine—over 12 months.
• Metabolic markers: May modestly influence glucose, A1c, and lipids when paired with weight loss and exercise.
• Cardiovascular safety: Large modern outcomes data show no increase in major cardiovascular events in appropriate patients, with targeted monitoring for blood pressure, atrial fibrillation, and clot risk.

Typical timelines: libido/energy within weeks; body composition and mood by months 2–3; bone and metabolic markers over 6–12 months.

Longevity & Healthy Aging Benefits

TRT isn’t a “life-extension drug,” but restoring testosterone to physiologic ranges can support multiple pillars of healthspan—when paired with sleep, resistance training, nutrition, and weight management. At Solvion Health, we frame TRT within a comprehensive longevity plan:

• Musculoskeletal resilience: Higher lean mass and bone density help maintain strength, mobility, and fall/fracture resistance.
• Metabolic stability: Improvements in visceral fat, insulin sensitivity, and lipids support long-term cardiometabolic health.
• Functional capacity: Better recovery and exercise tolerance enable higher training volumes, which are independently linked to healthier aging.
• Mood, drive, and adherence: Gains in energy and motivation improve consistency with the habits that drive longevity outcomes.
• Frailty risk mitigation: By countering sarcopenia and bone loss, TRT can contribute to lower frailty risk—tracked via DXA, grip strength, gait speed, and balance metrics.

Note: Longevity benefits are maximized by the stack—TRT + training, protein, sleep, and risk-factor control—not by testosterone alone.

Potential Risks & Side Effects (and How We Manage Them)

• Erythrocytosis (high hematocrit): Most common side effect. Many guidelines act around hematocrit ≥54% with dose changes, temporary holds, or route switches; evaluation often begins above ~50%.
• Skin & hair: Acne/oily skin; possible hair thinning in predisposed men; typically manageable.
• Fertility suppression: Exogenous testosterone lowers LH/FSH and suppresses sperm production; discuss alternatives (SERMs, hCG) or banking if you want children soon.
• Prostate & urinary: No evidence that physiologic TRT causes prostate cancer; monitor PSA and BPH symptoms per age/risk.
• Cardiometabolic nuance: We monitor blood pressure and individualized risks (e.g., prior clots or arrhythmias).

Delivery Methods: Pros, Cons, and Fit

• Injections (short-/long-acting): Flexible and cost-effective; may cause peaks/valleys—often reduced with smaller, more frequent doses.
• Transdermal gels/creams: Convenient, steady levels; avoid skin-to-skin transfer to others.
• Pellets: Long-acting convenience with less dose flexibility; minor in-office procedure.
• Nasal/buccal: Niche options when adherence or absorption is a challenge.

Solvion Health matches the route to your physiology, preferences, and budget.

Dosing & Monitoring at Solvion Health

Baseline labs: total/free testosterone (morning, repeat confirmation), CBC/hematocrit, PSA (age/risk-based), lipids, A1c/glucose, liver enzymes; screening for sleep apnea and fertility goals.

Follow-up cadence: recheck testosterone and safety labs at 6–12 weeks after starting or changing dose; then every 3–6 months during optimization; then every 6–12 months once stable (individualized).

Targets: symptom relief within normal physiologic testosterone ranges, guided by trough levels and safety labs—not chasing supraphysiologic numbers.

Longevity tracking add-ons: body-composition (DXA or BIA), waist-to-height ratio, fitness estimate (e.g., 12-min test), grip strength, gait speed/balance, sleep quality, and home or continuous BP logs.

Myths vs. Facts

• “TRT causes prostate cancer.” Not supported when men are screened and monitored; follow age/risk-appropriate PSA.
• “TRT is only for bodybuilders.” Proper TRT treats diagnosed hypogonadism and restores normal levels; misuse is not medical therapy.
• “Once you start, you can’t ever stop.” Therapy can be paused or tapered; some men use alternatives (SERMs/hCG) to align with fertility goals—clinician-guided.

Who Should Avoid or Delay TRT?

Active prostate or breast cancer, very high hematocrit, severe untreated obstructive sleep apnea, uncontrolled heart failure, or near-term fertility plans (unless on an alternative protocol) are typical reasons to avoid or delay therapy. Coordinate with your primary care clinician, cardiologist, or urologist as needed.

Why Choose Solvion Health (TRT Clinic in Houston)

• Physician-led evaluation with guideline-based testing and shared decision-making.
• Clear monitoring protocol (CBC/hematocrit, PSA, lipids, A1c, liver enzymes, blood pressure).
• Fertility counseling up front (hCG or SERM options if relevant).
• Transparent pricing for consults, labs, medications, and supplies.
• Local coordination for phlebotomy, sleep studies, and referrals.
• Longevity lens: We pair TRT with training, nutrition, and risk-factor control to maximize healthspan—not just testosterone levels.

Locations: Greater Houston • Telehealth options available

Cost & Insurance 101

Expect costs for initial consults/labs, medications/supplies, and ongoing monitoring. Some insurance plans cover parts of TRT for documented hypogonadism; others do not. Monitoring is non-negotiable—it keeps therapy effective and safe.

Results Timeline: What to Expect

• Weeks 2–4: libido and energy often improve first.
• Months 2–3: mood steadies; strength and body-composition trends become clearer.
• Months 3–6: dose fine-tuning; continued changes in fat/lean mass.
• 6–12+ months: bone and metabolic markers follow a longer horizon.

Frequently Asked Questions

Citations Summary (Plain-English Takeaways)

1. Endocrine Society Clinical Practice Guideline (2018): Who qualifies, how to test (morning, repeat), dosing targets, and what to monitor (CBC/hematocrit, PSA, lipids, A1c, liver enzymes).
2. American Urological Association (AUA) Guideline (2018; validity confirmed 2024): Diagnostic thresholds, workup, treatment options, and hematocrit action points commonly used in U.S. practice.
3. TRAVERSE Trial (NEJM 2023): >5,200 men with low T and cardiovascular risk factors; no increase in major adverse cardiovascular events vs. placebo over ~2 years; small increases in atrial fibrillation and pulmonary embolism noted.
4. FDA Labeling Updates (2025): Reflect TRAVERSE; emphasize blood-pressure warning and remove generalized CV-risk language; maintain caution for age-related low T.
5. Testosterone Trials (2016–2017 series): Moderate improvements in sexual function, mood/vitality, anemia; increases in bone density/strength over 12 months; one sub-study showed increased non-calcified coronary plaque volume informing risk-benefit discussions.
6. Erythrocytosis Management (2022–2025 literature): Erythrocytosis is the most common side effect; consider dose reduction/hold at hematocrit ≥54% and evaluate above ~50%.
7. Fertility Considerations (AUA/ASRM): TRT suppresses spermatogenesis; alternatives include SERMs and hCG when fertility is desired.